Naoki Okada Selected Research

Naoki Okada Research Topics

Disease

66	Neoplasms (Cancer) 01/2024 - 03/2002
8	Melanoma (Melanoma, Malignant) 12/2011 - 03/2002
7	Glaucoma 02/2024 - 06/2022
6	Asthma (Bronchial Asthma) 01/2024 - 01/2021
5	Infections 01/2023 - 05/2003
4	COVID-19 04/2023 - 07/2021
4	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2023 - 07/2021
4	Lymphoma (Lymphomas) 05/2022 - 03/2006
4	Inflammation (Inflammations) 10/2013 - 07/2002
4	Body Weight (Weight, Body) 04/2013 - 07/2002
4	Communicable Diseases (Infectious Diseases) 01/2013 - 05/2003
4	Neoplasm Metastasis (Metastasis) 09/2011 - 08/2006
3	Cataract (Cataracts) 02/2024 - 01/2023
3	Blister (Bulla) 12/2023 - 11/2022
3	Pneumonia (Pneumonitis) 01/2023 - 07/2021
3	Hemolysis 06/2013 - 01/2002
3	Carcinoma (Carcinomatosis) 11/2008 - 06/2005
2	Cicatrix (Scar) 12/2023 - 06/2023
2	Choroidal Effusions 06/2023 - 01/2022
2	Fibrosis (Cirrhosis) 06/2023 - 11/2022
2	Exfoliation Syndrome 01/2023 - 07/2021
2	Allergic Bronchopulmonary Aspergillosis 01/2023 - 10/2020
2	Carcinogenesis 08/2022 - 04/2022
2	Pain (Aches) 08/2022 - 07/2015
2	Liver Neoplasms (Liver Cancer) 04/2022 - 06/2010
2	Sarcoma (Soft Tissue Sarcoma) 09/2020 - 11/2006
2	Human Influenza (Influenza) 10/2017 - 07/2015
2	Seborrheic Keratosis 01/2017 - 10/2013
2	Tetanus 02/2012 - 01/2011
2	Diphtheria 02/2012 - 01/2011
2	Diabetes Mellitus 08/2005 - 08/2002
1	Esophageal Neoplasms (Esophageal Cancer) 02/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2024

Drug/Important Bio-Agent (IBA)

20	AntigensIBA 01/2020 - 05/2003
12	VaccinesIBA 03/2020 - 01/2005
8	Peptides (Polypeptides)IBA 01/2014 - 01/2007
8	Therapeutic UsesIBA 03/2010 - 03/2002
7	CytokinesIBA 04/2022 - 03/2002
7	ChemokinesIBA 11/2008 - 04/2004
6	Chimeric Antigen ReceptorsIBA 05/2022 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 06/2019 - 09/2007
5	LigandsIBA 04/2022 - 11/2007
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 03/2002
5	Liposomes (Liposome)IBA 02/2009 - 01/2006
5	arginyl-glycyl-aspartic acidIBA 02/2007 - 03/2002
4	Immunoglobulin G (IgG)IBA 11/2023 - 03/2006
4	Immune Checkpoint InhibitorsIBA 03/2023 - 08/2018
4	Single-Chain AntibodiesIBA 05/2022 - 03/2010
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2020 - 03/2010
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2011 - 09/2007
4	Thymidine KinaseIBA 09/2011 - 07/2005
4	OvalbuminIBA 06/2011 - 03/2006
4	Interleukin-12 (IL 12)IBA 11/2008 - 02/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 04/2022
3	Protein Kinase InhibitorsIBA 12/2023 - 11/2022
3	K-115IBA 12/2023 - 11/2022
3	InterleukinsIBA 01/2023 - 03/2002
3	Prostaglandins AIBA 10/2017 - 01/2010
3	HydrogelsIBA 02/2012 - 10/2008
3	Chemokine ReceptorsIBA 02/2007 - 05/2003
2	Immunoglobulin E (IgE)IBA 01/2024 - 11/2023
2	rho-Associated KinasesIBA 12/2023 - 11/2022
2	Ophthalmic Solutions (Eye Drops)IBA 12/2023 - 06/2023
2	AllergensIBA 11/2023 - 11/2022
2	RNA (Ribonucleic Acid)IBA 07/2023 - 01/2022
2	Heparin (Liquaemin)FDA LinkGeneric 04/2023 - 10/2013
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023 - 11/2022
2	Poly I-CIBA 01/2023 - 08/2022
2	AntibodiesIBA 01/2023 - 01/2010
2	InterferonsIBA 08/2022 - 04/2022
2	Peroxidase (Myeloperoxidase)IBA 04/2022 - 07/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2022 - 01/2022
2	Hemagglutinins (Hemagglutinin)IBA 10/2017 - 07/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017 - 10/2013
2	Messenger RNA (mRNA)IBA 01/2016 - 10/2013
2	LuciferasesIBA 08/2012 - 01/2010
2	CosmeticsIBA 08/2012 - 09/2010
2	ToxoidsIBA 06/2012 - 01/2011
2	Monophenol Monooxygenase (Tyrosinase)IBA 12/2011 - 07/2005
2	Glutamic Acid (Glutamate)FDA Link 06/2011 - 01/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2010 - 10/2007
2	poly(gamma-glutamic acid) (gamma-PGA)IBA 03/2008 - 02/2008
2	Integrin alphaVIBA 07/2005 - 04/2002
2	IntegrinsIBA 06/2005 - 04/2002
2	Complement System Proteins (Complement)IBA 11/2002 - 01/2002
2	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 04/2002 - 03/2002

Therapy/Procedure

30	Therapeutics 01/2024 - 08/2002
21	Immunotherapy 03/2023 - 04/2004
11	Trabeculectomy (Trabeculoplasty) 12/2023 - 07/2021
4	Phacoemulsification 05/2023 - 07/2021
3	Percutaneous Collagen Induction 12/2023 - 11/2022
3	Injections 07/2015 - 11/2007
2	Drug Therapy (Chemotherapy) 01/2022 - 08/2006
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 08/2005
1	Gastrectomy 02/2024
1	Esophagectomy 02/2024
1	Operative Time 02/2024
1	Intraocular Lenses (Intraocular Lens) 02/2024
1	Operative Surgical Procedures 02/2024